Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Plant-Derived Quadrivalent VLP Influenza Vaccine in Adults
NCT03301051Phase 3Completed
- Sponsor
- Medicago Inc.
- Start
- Aug 2017
- Primary completion
- May 2018
- Countries
- 7
01
Overview
Phase 3, randomised, double-blind trial in influenza (2 arms), sponsored by Medicago Inc. Primary endpoint: Number of Occurrences of Protocol-Defined Respiratory Illness Caused by Vaccine-Matched Influenza Strains. Started Aug 2017; status: completed.
02
Conditions
influenza
Beyond the preview
Go deeper on NCT03301051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03301051.